Good Manufacturing Practice 2024
Swiss/FDA Mutual Recognition Agreement – State of Play

Memox Peter-Merian Strasse 80, Basel, Switzerland

Join us in Basel, where Sidley and thought leaders will be discussing the FDA and Swissmedic Mutual Recognition Agreement on Good Manufacturing Practices for pharmaceutical products. This agreement aims to streamline regulatory processes and enhance cooperation between the two countries by recognizing each other’s GMP inspections, thereby reducing the need for duplicative inspections. RSVP here. We […]

Regulatory Know-How for Growth-Stage Life Sciences Innovators

Torrey Heights 11208 El Camino Real, San Diego, CA, United States

Please join Sidley’s Global Life Sciences team to lean into key early-stage and emerging growth regulatory issues, and how to tackle them. If have questions or are interested in attending, […]

Boston Life Sciences Roundtable

The Institute of Contemporary Art/Boston 25 Harbor Shore Drive, Boston, MA, United States

Join Sidley’s Life Sciences team for an afternoon of thought-provoking and engaging discussions touching on the latest trends and hot topics including the new administration, new technologies, the investment landscape, […]

Women’s Life Sciences Network Event – Brussels

Comet Place Stephanie 50, Brussels, Belgium

Join us in Brussels for our next Women’s Life Sciences Network event on the occasion of the EU Pharmaceutical Law Forum. The event will feature a moderated discussion with Rainer Becker, Director, DG SANTE, European Commission, on topical issues of pharmaceutical legislation and policy. Stay tuned for a formal invitation and additional speaker announcements coming soon.

Sidley Healthcare Investment Conference 2025

The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK The Francis Crick Institute, 1 Midland Road, London, United Kingdom

With deal and investment activity remaining critical to the success of the life sciences and healthcare industry, Sidley is bringing together senior pharma, biotech, healthcare, private equity, and venture capital […]